Reha Technology

About Reha Technology

Reha Technology AG is a Swiss medical technology company, founded in 2011, that specialized in the design and manufacturing of robotic-assisted devices for neurological rehabilitation. The firm's primary objective was to help patients with movement disorders, resulting from conditions like stroke, spinal cord injuries, or Parkinson's, to regain independence in their daily lives. Headquartered in Olten, Switzerland, the company established a global distribution network, including direct operations in the USA and Germany, to serve its clientele of hospitals, clinics, and therapy centers.

The company's core product line, the G-EO System, was a sophisticated robotic gait trainer developed over more than a decade. This system is based on the end-effector principle, where the patient's feet are guided by robotic footplates to simulate a natural physiological gait pattern. This approach allows for high-intensity, repetitive, and task-oriented movements, which are crucial for effective neurorehabilitation. A key differentiator of the G-EO System was its ability to realistically simulate not just level ground walking but also ascending and descending stairs and slopes. The technology was designed to be highly versatile, with modular components and various operational modes—passive, active-assistive, and active—to cater to a wide spectrum of patient impairments, from pediatric to adult cases. The system provided real-time feedback and data reporting to track patient progress, enhancing the value for therapists, physicians, and insurers.

The business model centered on selling these high-tech robotic systems directly to rehabilitation facilities and through a network of distributors. The value proposition for these clients was increased therapy efficiency, reduced physical strain on therapists, and improved patient outcomes. In July 2017, the company announced it had received FDA approval for an integrated Functional Electrical Stimulation (FES) feature for the G-EO System, further enhancing its therapeutic capabilities. However, despite its technological advancements, Reha Technology faced significant financial difficulties. The company announced on July 23, 2025, that it had filed for bankruptcy and would cease operations immediately, citing substantial debt incurred prior to 2019 and a challenging market environment exacerbated by the COVID-19 pandemic, which limited capital investment in the healthcare sector. Support for existing customers is planned to continue through its global sales and service partners.